Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BCLI
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Brainstorm Cell Therapeutics Inc. stock price on Thursday moving between $0.490 and $0.600
(Updated on Mar 28, 2024)

Buy or Hold candidate since Mar 19, 2024 Gain 58.76% PDF

The Brainstorm Cell Therapeutics Inc. stock price fell by -5.91% on the last day (Thursday, 28th Mar 2024) from $0.600 to $0.565. During the last trading day the stock fluctuated 22.43% from a day low at $0.490 to a day high of $0.600. The price has risen in 6 of the last 10 days and is up by 71.85% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -627 thousand shares and in total, 640 thousand shares were bought and sold for approximately $361.49 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 36.77% during the next 3 months and, with a 90% probability hold a price between $0.470 and $0.91 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BCLI Signals & Forecast

The Brainstorm Cell Therapeutics Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.577. On a fall, the stock will find some support from the long-term average at approximately $0.394. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, March 26, 2024, and so far it has fallen -14.44%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Brainstorm Cell Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.507 and $0.480. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $0.480 may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.110 between high and low, or 22.43%. For the last week the stock has had daily average volatility of 27.46%.

Our recommended stop-loss: $0.533 (-5.56%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (BCLI) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Brainstorm Cell Therapeutics Inc. to open at $0.552, and during the day (based on 14 day Average True Range), to move between $0.481 and $0.648, which gives a possible trading interval of +/-$0.0833 (+/-14.75%) up or down from last closing price. If Brainstorm Cell Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 29.49% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.570 (0.94%) than the support at $0.507 (10.22%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Brainstorm Cell Therapeutics Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Brainstorm Cell Therapeutics Inc. stock to perform well in the short-term.

Current score: 2.568 Buy Candidate Unchanged

Predicted Opening Price for Brainstorm Cell Therapeutics Inc. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$0.552 ( 2.33%) $0.565

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BCLI

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.661 17.13 %
R2 0.619 9.70 %
R1 0.594 5.10 %
Current price: 0.565
Support S1 0.510 -9.77 %
S2 0.484 -14.36 %
S3 0.442 -21.79 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.660 16.88 %
R2 0.655 15.99 %
R1 0.570 0.94 %
Current price 0.565
Support S1 0.507 -10.22%
S2 0.480 -15.00%
S3 0 .

FAQ

What is the symbol for Brainstorm Cell Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Brainstorm Cell Therapeutics Inc. is BCLI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Brainstorm Cell Therapeutics Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Brainstorm Cell Therapeutics Inc. stock to perform well in the short-term.

How to buy Brainstorm Cell Therapeutics Inc. Stock?
Brainstorm Cell Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Brainstorm Cell Therapeutics Inc. Stock.

What's the current price of Brainstorm Cell Therapeutics Inc. Stock?
As of the end of day on the 2024-03-28, the price of an Brainstorm Cell Therapeutics Inc. (BCLI) share was $0.565.

What is the 52-week high and low for Brainstorm Cell Therapeutics Inc. Stock?
The 52-week high for Brainstorm Cell Therapeutics Inc. Stock is $3.46 and the 52-week low is $0.135.

What is the market capitalization of Brainstorm Cell Therapeutics Inc. Stock?
As of the 2024-03-28, the market capitalization of Brainstorm Cell Therapeutics Inc. is 29.399M.

When is the next earnings date for Brainstorm Cell Therapeutics Inc.?
The upcoming earnings date for Brainstorm Cell Therapeutics Inc. is Apr 04, 2024.
Click to get the best stock tips daily for free!

About Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative ... BCLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT